Related Experiment Video
Updated: Jan 25, 2026

Author Spotlight: Plant Primary Organs Profiling Using 13C6-Glucose Labeling and LC-MS
Published on: March 22, 2024
Long-term, low-dose aspirin is safe in glucose-6-phosphate dehydrogenase deficiency
1Department of Medicine, Hadassah University Hospital, Mount Scopus, Jerusalem, Israel.
Abstract:
Forty-four patients with Mediterranean-type glucose-6-phosphate dehydrogenase (G-6-PD) deficiency receiving long-term, low-dose aspirin were monitored over three months for evidence of hemolysis. Complete blood count, reticulocyte count and serum bilirubin were normal in all patients before treatment and upon periodic retesting. We conclude that there is sufficient current evidence to remove the hemolytic stigma of aspirin in G-6-PD deficiency, thereby establishing its safety for long-term therapy in this condition.
Related Concept Videos
Dose Size and Dosing Frequency: Determination Methods
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
Phosphate Buffer
Sodium dihydrogen phosphate does not fully dissociate in neutral or acidic solutions. When a strong base, such as sodium hydroxide (NaOH), is introduced into the solution, sodium dihydrogen phosphate...
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Guidelines and Strategies for Safe Computer Charting
Maintain Confidentiality and Security:
Long-term Depression

